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Abstract
Objective To estimate the degree of scatter of reports of randomised
trials and systematic reviews, and how the scatter differs among medical
specialties and subspecialties.
Design Cross sectional analysis.
Data source PubMed for all disease relevant randomised trials and
systematic reviews published in 2009.
Study selection Randomised trials and systematic reviews of the nine
diseases or disorders with the highest burden of disease, and the broader
category of disease to which each belonged.
Results The scatter across journals varied considerably among
specialties and subspecialties: otolaryngology had the least scatter (363
trials across 167 journals) and neurology the most (2770 trials across
896 journals). In only three subspecialties (lung cancer, chronic
obstructive pulmonary disease, hearing loss) were 10 or fewer journals
needed to locate 50% of trials. The scatter was less for systematic
reviews: hearing loss had the least scatter (10 reviews across nine
journals) and cancer the most (670 reviews across 279 journals). For
some specialties and subspecialties the papers were concentrated in
specialty journals; whereas for others, few of the top 10 journals were
a specialty journal for that area. Generally, little overlap occurred between
the top 10 journals publishing trials and those publishing systematic
reviews. The number of journals required to find all trials or reviews was
highly correlated (r=0.97) with the number of papers for each
specialty/subspecialty.
Conclusions Publication rates of speciality relevant trials vary widely,
from one to seven trials per day, and are scattered across hundreds of
general and specialty journals. Although systematic reviews reduce the
extent of scatter, they are still widely scattered and mostly in different
journals to those of randomised trials. Personal subscriptions to journals,
which are insufficient for keeping up to date with knowledge, need to be
supplemented by other methods such as journal scanning services or
systems that cover sufficient journals and filter articles for quality and
relevance. Few current systems seem adequate.
Introduction
Research output doubles about every seven years.1 This
continuing expansion is both a blessing and a curse. The
improvement in our collective knowledge and ability to diagnose
and manage illness has the potential to benefit patients globally.
The potential gains are, however, inhibited by the information
overload experienced by clinicians struggling to keep abreast
of new research. Growth in the number of both articles and
journals means reports of new developments are increasingly
scattered, with no corresponding increase in the amount of time
that clinicians can devote to reading.
Two responses to cope with the expansion of knowledge have
been better organisation and synthesis of articles, such as
systematic reviews and guidelines, and increasing
subspecialisation of clinicians. Systematic reviews are an attempt
to reduce the scatter of trials by synthesising the best research
for a specific clinical question through systematic searching for
and appraising and (sometimes) pooling of the scattered
research. To save clinicians from needing to read all the primary
trials, the Cochrane Collaboration aims to publish up to date
systematic reviews in all areas of medicine, although it is still
far from achieving this goal.2 Even if up to date systematic
reviews were available for all questions, the number of, and
subcategorisation of diseases, diagnostic tools, and treatments
also continues to grow rapidly. Hence subspecialisation has
been an alternative response to the knowledge expansion but
brings its own problems of fragmented care and rising costs.
Both responses—better organisation and
subspecialisation—have contributed to increasing the scatter of
research (the spread of journal articles for a particular subject
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across multiple journals3), which seems to be an inevitable
consequence of its growth. Previous work has suggested that
this scatter of research has a long tail. For example, in renal
medicine 49% of 2779 renal studies (derived from 195
systematic reviews) were in 20 journals, half renal and half
non-renal, whereas the remaining 51% were scattered across
446 journals.4 The distribution has been characterised by
Bradford’s law, which states that if journals in a discipline are
sorted by number of articles into three groups, each with about
one third of all articles, then the number of journals in each
group will be proportional to 1:n:n². Twomethods that clinicians
can use to keep up to date with research are targeted searching
for answers to specific clinical questions or general scanning
of a selected number of journals, with research suggesting that
the latter strategy is used much more. For example, 79% of the
articles last read by paediatricians were identified through
browsing journals to which they personally subscribed and only
8% were located through searching.5 General scanning can be
done directly or through the increasingly popular “journal
scanning services,” which collate articles from across numerous
journals. We focused on the general scanning strategy, whether
by personal subscription or scanning service, as the feasibility
of this strategy for locating relevant recent research in unknown,
before considering factors such as the quality of the articles
located. We determined how the scattering of randomised trials
and systematic reviews differed across medical specialties and
subspecialties and examined the implications of this scatter for
keeping up to date with research.
Methods
Selection of specialties and subspecialties
We were interested in examining how the scatter of research
differs across various specialties and subspecialties, as this
impacts on the number of journals that clinicians need to read.
SinceMedical Subject Headings (MeSH) coding of randomised
trials and systematic reviews refers more to the health condition
than to the area of specialty, we focused on MeSH terms for
selected diseases and disorders. For example, for psychiatry we
searched for “mental disorders,” and for cardiology we searched
for “heart diseases.” Throughout the results and discussion,
however, wemainly refer to the correspondingmedical specialty
(psychiatry and cardiology, for example) rather than to the
disease or disorder.
Our choice of the sample of specialities to study was informed
by burden of disease. Using the World Health Organization
Global Burden of Disease report,6 we chose the nine diseases
or disorders that made the leading contributions to the burden
of disease in high income countries: depressive disorders,
ischaemic heart disease, cerebrovascular disease, dementias,
alcohol use disorders, hearing loss, chronic obstructive
pulmonary disease, diabetes mellitus, lung cancers (the 10th
was road traffic accidents which involves many specialties).
We then chose the broader category of disease to which each
of these diseases or disorders belongs; for example, lung cancer
in the broader category of cancer. Three of the diseases/disorders
(depression, dementia, alcohol related disorders) belonged to
the one category (mental disorders), resulting in seven specialties
and nine subspecialties analysed in this study.
Search strategy
An experienced medical librarian (ST) carried out the searches
in PubMed on 14 April 2011. We selected the publication year
2009 to ensure that indexing would be complete: most indexing
is complete by March of the following year (PubMed, personal
communication, 2012). Each search string consisted of aMeSH
term to identify the selected disease or disorders, a publication
type to identify the type of study, and the year of publication.
For example, the search strategy for randomised trials in
cardiology was: “heart diseases”[MeSH] AND randomised
controlled trial[pt] AND 2009[dp]. When compared with 37
other search filters, the Medline/PubMed filter of randomised
controlled trial as publication type had the highest precision, as
well as high sensitivity and specificity.7 Although our search
may have retrieved some randomised phase 2 trials, most such
studies are not randomised trials. In oncology, for example,
96% of trials have been reported as single arm studies.8 To
identify systematic reviews we searched using “meta-analysis”
as publication type, as this strategy has been shown to be one
of the highest performing single search terms for maximising
precision when retrieving systematic reviews.9 Results for each
search were saved in separate EndNote libraries.
Data extraction and analysis
References from each search were exported from EndNote into
Excel, and for each disease set we sorted studies by journal then
counted the number of articles and journals. This was done
separately for randomised trials and systematic reviews. For
each specialty and subspecialty we calculated, separately, the
number of journals that would need to be read to locate all the
randomised trials and systematic reviews as well as the number
to locate half of the randomised trials and half of the systematic
reviews (which we designate the J50 value).
For the 10 journals that had published the highest number of
papers (separately for randomised trials and systematic reviews)
for each specialty and subspecialty in 2009 (the “top 10” journal
list), we classified the journals as specialty, subspecialty, other
specialty (for example, a trial of an intervention for patients
with diabetes published in a cardiology journal), or general
medical. The classification was done independently by two
researchers (TH and PG), who then discussed and resolved any
disagreements.
Results
Scatter of randomised trials and systematic
reviews
For the selected specialties and subspecialties, 14 343
randomised trials and 3214 systematic reviews were published
in 2009. The correlation between the number of papers and the
number of journals in a discipline was high (Pearson’s
correlation coefficient r=0.97, fig 1⇓). The largest number of
randomised trials (n=2770) was in neurological diseases,
published in 896 journals; in contrast, 26 randomised trials
related to hearing loss were published in 21 journals. The largest
number of systematic reviews (n=670) was in cancer, published
in 279 journals. Hearing loss had the smallest number, with 10
systematic reviews published in nine journals.
Figure 2⇓ shows the scatter of randomised trials and systematic
reviews for each of the specialties and subspecialties. For
example, an estimated 29 journals would need to be read to
locate 25% of the randomised trials on neurological disease,
114 to locate 50%, and 896 journals to locate all trials. The
range of scatter varied considerably across specialties, but with
a similar shape. The plots all show a long tail of journals with
few randomised trials or systematic reviews, but a logarithmic
version of figure 2 (not shown) is slightly convex, suggesting
an imperfect fit with Bradford’s law. The third group contained
an average of 30% fewer journals than predicted by Bradford’s
1:n:n2 formulation.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e3223 doi: 10.1136/bmj.e3223 (Published 17 May 2012) Page 2 of 9
RESEARCH
 o
n
 26 M
ay 2019 by guest. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.e3223 on 17 May 2012. Downloaded from 
The table⇓ shows the number of journals needed to locate 50%
and 100% of the randomised trials and systematic reviews for
each specialty and subspecialty. For only three subspecialties
(lung cancer, chronic obstructive pulmonary disease, hearing
loss) and no specialities 10 or fewer journals needed to be read
to locate 50% of the papers of the randomised trials for that
area. Similarly for systematic reviews, these three subspecialties,
along with alcohol related disorders and otolaryngological
diseases, were the only areas in which 10 or fewer journals
needed to be read to locate 50% of the papers.
Journals publishing the highest number of
randomised trials and systematic reviews
For five of the seven specialties (endocrinology, oncology,
neurology, pulmonology, and cardiology), the journal that had
published the highest number of randomised trials was the same
as the journal that had published the highest number of
randomised trials in the corresponding subspecialty (table). For
six of the seven specialties and four of the nine subspecialties,
the Cochrane Database of Systematic Reviews had published
the highest number of systematic reviews, publishing between
6% and 18% of all the systematic reviews published in each
area in 2009.
For three specialties (endocrinology, cardiology, and oncology)
and two subspecialties (myocardial infarction, chronic
obstructive pulmonary disease) some overlap was evident
between the top 10 journals that had published randomised trials
and the top 10 journals that had published systematic reviews,
with five or more journals appearing in both lists. The remaining
areas showed little similarity. A journal’s impact factor was not
related to its ranking in the top 10 journals (by proportion of
papers published), for either randomised trials or systematic
reviews (see supplementary figure).
Types of journals
Figure 3⇓ shows the classification of the top 10 journals
(separately for randomised trials and systematic reviews) for
each specialty and subspecialty either as a journal of that
specialty, subspecialty, other specialty, or as a general medical
journal.
Randomised trials
For some specialties and subspecialties the randomised trials
were concentrated in specialty journals. For example, in
cardiology, myocardial infarction, chronic obstructive
pulmonary disease, and alcohol related disorders seven or more
specialty journals were in the top 10 journals publishing relevant
randomised trials. In contrast, for dementia, depression, stroke,
and neurology, only one of the top 10 journals publishing
randomised trials was a specialty journal for that area. Most
(n=9) of the top 10 journals that published randomised trials on
depression were journals that specialise in areas other than
depression (for example, Patient Education and Counseling),
and for neurology, seven of the top 10 journals were other
specialty journals (for example,Clinical Rehabilitation). General
medical journals were not in the top 10 journals publishing
randomised trials for any specialty, but were for four
subspecialties: lung cancer (two of the top 10 journals), stroke
(n=1), myocardial infarction (n=1), and hearing loss (n=1).
Systematic reviews
For some specialties and subspecialties the systematic reviews
were concentrated in specialty journals. For example, oncology,
lung cancer, and psychiatry each had six or more specialty
journals in the top 10 journals. In contrast with randomised
trials, at least one (range 1-3) of the top 10 journals for each
specialty and subspecialty, with the exception of lung cancer,
was a general medical journal. The Cochrane Database of
Systematic Reviews was the most common general medical
journal. For the subspecialties of hearing loss, dementia, and
depression, at least half of the top 10 journals that had published
systematic reviews were journals that specialise in areas other
than these subspecialties (for example, systematic reviews on
hearing loss published in Ageing Research Reviews).
Discussion
Randomised trials and systematic reviews were widely scattered
across a large number of journals. Within a discipline, the
number of journals required to find all trials or reviews was
closely related to the number of papers. The extent of scatter
varied among the specialties and subspecialties. Otolaryngology
had the lowest number of published papers and hence the lowest
extent of scatter; neurology had the highest number of papers
and the greatest extent of scatter (896 journals for all trials).
Neurology’s extensive scatter may result from its wide range
of conditions and its overlap with other specialties such as
psychiatry and internal medicine.10 For example, the top 10
journals publishing randomised trials on dementia comprised
journals in the areas of gerontology, psychiatry, neurology,
dementia, and randomised trials.
To find even half of the papers published in one year (that is,
the J50), a clinician would need to read an impracticable number
of journals; for example, an estimated 39 journals for
randomised trials on diabetes and 23 journals for systematic
reviews on myocardial infarction. For a few areas the numbers
might be feasible, for example, lung cancer (for both randomised
trials and systematic reviews nine journals would need to be
read to locate 50% of relevant articles), chronic obstructive
pulmonary disease (10 journals for randomised trials and six
for systematic reviews), and hearing loss (eight for randomised
trials and four for systematic reviews). The problem is
compounded by a small overlap between the top 10 journals
publishing randomised trials and those publishing systematic
reviews.
Limitations of the study
Our study has some limitations. The sample of papers was
restricted to a single year and the analysis to seven specialties
and nine subspecialties based on burden of disease. Also, our
search strategy relied on PubMed’s publication type to retrieve
randomised trials and systematic reviews and therefore may
have missed some eligible papers and included some that are
not truly systematic reviews or randomised trials. It is likely
that we missed some eligible papers; however, locating
additional papers should only increase further the estimated
scatter. Scatter is also likely to be greater in specialties that
typically concern patients with a wide variety of conditions.
Examples include emergency medicine, primary care, palliative
care, and allied health disciplines, such as occupational therapy
and physiotherapy. These practice areas are not covered by a
singular subtree of the MeSH coding system, which further
impedes retrieval of relevant articles by clinicians who work in
these areas.
Comparison with other published work
Previous work has examined scatter within specific disciplines.
A bibliometric analysis of 195 systematic reviews on renal
conditions4 found that relevant articles were scattered across a
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large number of journals, in a pattern consistent with Bradford’s
law, and that about half of relevant research was published in
non-renal journals. An analysis of 103 792 randomised trials,
retrieved from Medline for a 12 year period, divided articles
into four zones and found that the number of journals in each
zone was similar to what Bradford’s law predicts, except for a
much larger fourth zone.1 In our study, the final third showed
less scatter than predicted by Bradford’s law, but this may be
explained by our focus on a single year of randomised trials and
systematic reviews.Many journals publish fewer than one paper
per year in the specialties/subspecialties selected for this study
and will not have been included in our sample, but those
publishing many well have been.
Consequences of research scatter
The main concern of this scatter is that trials and systematic
reviews are published in more journals than clinicians can
feasibly read to keep up to date with research. Surveys suggest
that the median number of journals read by psychiatrists is 10
for those with academic commitments and three for those
without11; non-academic pediatricians reported reading amedian
of six (range 5-8) journals and 21% of respondents read three
or fewer journals; and for surgeons, a mode of six journals for
academics and four for non-academics was reported.12Browsing
a few key journals that are perceived as pertinent to clinical
practice is a technique reported by clinicians as a means of
keeping up to date with new research.13 14 In surveys of the
reading habits of three separate groups of specialists
(paediatricians, psychiatrists, and surgeons), most reported
reading two key journals—one in their specialty area and one
in a general medical journal.11 12 15 Analysis of digital access to
full text articles by primary care doctors and specialists over an
18 month period found that the clinicians only accessed 38%
of the journal titles available to them, and, of these, showed
high use of a few journals and much lower use of other
journals.16 Specialists accessed a higher number of specialist
journals and overall accessed journals almost twice as often as
primary care doctors.
The results of our study highlight that clinicians who read or
subscribe to journals in their specialty only are likely to miss
many new relevant papers as many were published in other
types of journals. This was more of a problem for some
specialties/subspecialties, such as depression and neurology.
As some important and influential papers are published in low
circulation or low impact journals,17 these articles are likely to
be missed by clinicians who arbitrarily choose a few journals
to scan for up to date information. In an analysis of digital
accesses, other than a small set of “core” journals there was
little consistency about which additional journals doctors
accessed,16 suggesting that beyond a few key journals, it may
be intuition rather than a considered decision that guides
clinicians’ selection of journals to browse. The patterns differed
between randomised trials and systematic reviews, with general
medical journals appearing more often in the top 10 journals
publishing systematic reviews than in those publishing
randomised trials, even after excluding theCochrane Database
of Systematic Reviews from the systematic review journal list.
Another consequence of scatter is the trend for increasing
subspecialisation of specialties. For example, many oncologists
feel pressure to specialise in a single tumour type, and
proliferation of subspecialisation is likely to continue, with a
major driver of this being the pressure to keep up to date with
new knowledge.18 However, while subspecialisation may be
occurring in high density areas, in many towns specialists see
patients across the whole range of their specialty and therefore
need to keep up to date with developments in research across
the specialty. Scatter makes this difficult.
Possible solutions to managing scatter
As the number of papers and journals increases, scatter is likely
to increase. A yearly growth rate of 11% has been estimated for
randomised trials1 and 3.5% for journals19; the latter resulting
in a doubling of the number of journals every 20 years.19 Since
their inception, randomised trials and systematic reviews have
been growing exponentially, with no signs of plateau in this
growth.2 Hence solutions are clearly needed to help clinicians
cope with the increasing volume and scatter of research
publications. Different solutions have been proposed in different
disciplines, and the successes and failures of these might be
worth examination. Firstly, systematic reviews, which gather
and synthesise the data from randomised trials, are an important
element of any solution. An initial hope of the Cochrane
Collaboration was to act as a central library of systematic
reviews, organised by specialty, but Cochrane reviews have not
become the solution that was hoped. Some of the reasons are
that only about 1 in 10 new systematic reviews are published
in the Cochrane Database of Systematic Reviews,20 a large
proportion of Cochrane reviews are out of date,21 and Cochrane
reviews are perceived by clinicians as less clinically relevant
and newsworthy than non-Cochrane systematic reviews.22Hence
there is also a need to manage the scatter of systematic reviews,
for example, through a registry of planned and completed
systematic reviews, such as www.crd.york.ac.uk/prospero.23 A
registry would, in addition to providing a single location in
which to find reviews, provide benefits such as helping to
manage the increasing problem of publication bias, avoid
duplication of reviews (by ensuring title registration of reviews,
as occurs for Cochrane systematic reviews), and provide greater
transparency.24 Such registries may still be difficult for clinicians
to navigate, however, and some filtering and summarisation
will usually be needed. For example, the WHO Reproductive
Health Library (http://apps.who.int/rhl/resources/about/en/) is
an electronic review journal that summarises the best available
evidence on sexual and reproductive health from Cochrane
systematic reviews and presents it along with practical actions
for clinicians (and policy makers).
A related option is to develop specialist databases, journals, and
journal scanning services that collate scattered higher level
research papers in a single resource. For example, the ACP
Journal Club, sourced from over 120 journals, summarises the
best evidence in internal medicine in the form of a structured
abstract and clinical commentary. Journal scanning services are
often touted as a solution to keeping up to date and are available
for some of the specialties/subspecialties analysed in this study.
We examined the journal scanning services that we could
identify relevant to these specialties (through our own searching
and a request to the Evidence-Based Health Care email list) and
found only one that seemed to deal with the problems of wide
scatter and variable quality—the free service provided by the
BMJ Group’s EvidenceUpdates and the McMaster Premium
Literature Service Team (http://plus.mcmaster.ca/
EvidenceUpdates/), which scans over 120 journals, filters
articles on the basis of quality, has practising clinicians rate
them for relevance and newsworthiness, and makes them
available as email alerts and in a searchable database. However,
this scanning service focuses mostly on the generalist physician
and many specialties are not covered. Of the other services,
common problems included no listing of journals searched or
frequency of searching, inclusion of all article types including
all study designs and news items, no filtering for quality, no
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transparent or explicit process for the inclusion of articles, or
industry sponsorship. Of the twomajor journal scanning services
that did list the journals scanned, there was poor mismatch
between the journals they scanned and the top 10 journals
identified in our study: for randomised trials an average match
of 5.5 (range 0-9) journals and for systematic reviews an average
match of 4.5 (range 1-8) journals (full data available from
authors on request). If done well, journal scanning services may
be part of the solution to managing research scatter, but if not
(which currently seems to be the case for most services) they
may inadvertently be encouraging selective reading and giving
clinicians the illusion that they are keeping up to date. Scanning
services are unlikely to be the sole solution to scatter though.
It has been reported that clinicians rarely retrieve synopses of
new research for which they receive email alerts.25
To manage the problem of research scatter in allied health,
specialised databases that collate and critically appraise
randomised trials and systematic reviews relevant to
occupational therapy (www.otseeker.com) and physical therapy
(www.pedro.org.au) have been developed and are well used.26
Trials and reviews are primarily located through regular
systematic searches across multiple databases, the results
screened, and eligible papers retrieved and appraised.27 28 The
use of social media tools to alert clinicians to important new
research is an emerging area that may be useful in helping
clinicians to cope with scatter. However its potential to do so,
including structures and safeguards that would be needed, should
be explored in research.
Each specialty should consider which types of resource may
provide the greatest benefit for their clinicians. Although the
development and maintenance of such resources requires a
dedicated team to assume responsibility, lack of investment in
knowledge organisation is a contributor to the enormous problem
of worldwide waste in research evidence and funding.29 This
problem is one that can be rectified, at least partially, through
solutions such as those suggested. The resources needed will
be substantial but small compared with the $100bn (£62bn;
€76bn) spent on medical research annually, much of which is
wasted because it is unusable or unused.29
Conclusion
Despite its caveats, our study highlights the extent of a barrier
that can prevent clinicians from keeping up to date with new
research evidence in their specialty. Raising awareness of the
problem is an important first step towards generating solutions
to minimise the impact of this problem on the use of research
evidence in clinical practice.
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What is already known on this topic
Research papers, and the number of journals publishing them, have grown exponentially, making it difficult for clinicians to keep up to
date with new research
To keep up to date, most clinicians scan a selected number of paper or electronic journals
This is unlikely to be an effective strategy, but how much the scatter of research across journals differs among specialties is not known
What this study adds
Publication rates of speciality relevant trials vary widely (1-7 trials per day) and are scattered across hundreds of general and specialty
journals
Although systematic reviews reduce the extent of scatter, they are still widely scattered and mostly in different journals to those containing
randomised trials
Subscriptions to journals need to be supplemented by other methods such as journal scanning services or systems that cover sufficient
journals and filter for quality and relevance, but few current systems seem adequate
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Table
Table 1| Number of journals needed to locate 50% and 100% of randomised trials and systematic reviews published in 2009, for each
specialty and subspecialty
Journals
in
Systematic reviewsRandomised trialsSpecialty/subspecialty
No of journals to
locate 50% and
100% (50%; 100%)
Journal publishing highest No (%
published)
No of journals to
locate 50% and
100% (50%; 100%)
Journal publishing highest No
(%published) common
for both
article
types, top
10
631; 142Cochrane Database of Systematic
Reviews (7)
48; 447Diabetes Care (6)Endocrine system
diseases
422; 93Cochrane Database of Systematic
Reviews (6)*
39; 342Diabetes Care (8)Diabetes
538; 279Cochrane Database of Systematic
Reviews (6)
41; 503Journal of Clinical Oncology (10)Cancer
39; 41Lung Cancer (16)9; 68Journal of Clinical Oncology (15)Lung cancer
253; 292Cochrane Database of Systematic
Reviews (12)
114; 896Stroke (2)Neurological diseases
114; 88Stroke (18)19; 180Stroke (13)Stroke
322; 143Cochrane Database of Systematic
Reviews (18)
50; 460European Respiratory Journal (3)Respiratory diseases
56; 21Chest (13)10; 74European Respiratory Journal
(11)
Chronic obstructive
pulmonary disease
626; 145European Heart Journal (5)28; 374American Journal of Cardiology
(5)
Heart diseases
523; 96Atherosclerosis (5)19; 252American Journal of Cardiology
(8)
Myocardial infarction
334; 231Cochrane Database of Systematic
Reviews (9)
55; 545Journal of Clinical Psychiatry (3)Mental disorders
015; 36Cochrane Database of Systematic
Reviews (12)
51; 214Patient Education and
Counseling (2)†
Depression
212; 38Cochrane Database of Systematic
Reviews (17)
14; 70Journal of the American Geriatric
Society (5)
Dementia
29; 21Cochrane Database of Systematic
Reviews (9)‡
12; 70Alcoholism, Clinical and
Experimental Research (9)
Alcohol related disorders
39; 41Cochrane Database of Systematic
Reviews (11)
79; 167European Archives of
Oto-rhino-laryngol (4)
Otolaryngological
diseases
14; 9International Journal of Pediatric
Otorhinolaryngology (20)
8; 21Journal of Laryngology and
Otology (15)
Hearing loss
*Equal number of systematic reviews also published in Diabetes Care.
†Equal number of randomised trials also published in Journal of Consulting and Clinical Psychology, Psychooncology, and Trials.
‡Equal number of systematic reviews also published in Addiction.
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Figures
Fig 1 Number of randomised trials and systematic reviews for each specialty/subspecialty published in 2009 compared
with number of journals in which they were published. COPD=chronic obstructive pulmonary disease
Fig 2 Number of journals compared with percentage of randomised trials and systematic reviews in 2009 (total number in
brackets) by specialty (in bold) and subspecialty. COPD=chronic obstructive pulmonary disease
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Fig 3 Proportion of each journal type in top 10 journals for randomised trials and systematic reviews for each
specialty/subspecialty. COPD=chronic obstructive pulmonary disease. *Systematic reviews were scattered across nine
journals
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